FDA Grants Fast Track Designation to BNT325/DB-1305 for Plat

FDA grants fast-track status to BNT325/DB-1305 for patients with platinum-resistant ovarian epithelial, fallopian tube, or primary peritoneal cancer.

Related Keywords

China , Vivian Gu , Esmo Congress , , Ovarian Cancer , News ,